2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theAntiemetics And Antinauseants Market?

The growth of the antiemetics and antinauseants market is driven by the rising prevalence of cancer. Chemotherapy is a commonly recommended form of treatment for cancer, and its side effects usually include chemotherapy-induced nausea and vomiting (CINV). Antiemetics have been found to prevent CINV in approximately 60%-70% of patients. For instance, The American Cancer Society, a non-profit body based in the United States, forecasted in April 2024 that around 609,000 deaths from cancer and a projected 1.9 million new cancer diagnoses were made in the nation in 2022. It’s projected that 620,000 cancer-related deaths are expected, indicating a slight increase in mortality rates by 2024. The surge in cancer cases is set to boost the demand for antiemetics and antinauseants, thereby pushing up the market’s revenue.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

How Will the Growth Rate of theAntiemetics And Antinauseants Market Impact Industry Trends by 2034?

In recent times, we’ve seen a consistent enlargement of the antiemetics and antinauseants market. The market, poised to increase from $8.11 billion in 2024 to $8.45 billion in 2025, is projected to have a compound annual growth rate (CAGR) of 4.3%. The factors contributing to the growth during the historic phase can be traced back to traditional branding and market competitiveness, historical treatment preferences, economic circumstances, past global health occurrences, and developments in medical research and advancements.

The market size for antiemetics and antinauseants is poised to witness consistent expansion in the ensuing years, reaching a value of $9.7 billion by 2029, growing at a compound annual growth rate (CAGR) of 3.5%. The growth during the forecast period is a result of various contributing factors such as research and development efforts, economic influences, market competition, industry trends, shifts in illness patterns and healthcare regulations and policies. Some of the dominant trends predicted for the forecast period encompass heightened attention towards the patient’s experience, evolving healthcare policies, a consumer inclination towards non-invasive therapies, an increasing incidence of nausea related to chemotherapy and pregnancy, as well as the advent of targeted treatments.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2441

What Key Market Trends and Innovations Are Shaping the Future of theAntiemetics And Antinauseants Industry?

Key players in the antiemetic and antinauseant markets are focusing on product innovation like ready-to-use injectables to simplify treatment procedures and increase patient adherence. These ready-to-use solutions aim for instant effectiveness, simplifying the steps and reducing the time involved with conventional injectable medicines. Amneal Pharmaceuticals, a specialty pharmaceutical firm based in the United States, introduced FOCINVEZ, the first ever fosaprepitant ready-to-use injectable formulation in July 2024. This formulation helps tackle acute and prolonged nausea and vomiting linked to highly emetogenic cancer chemotherapy. The product comes in a 150 mg/50 ml vial, without the presence of Polysorbate 80, and demands no dilution or reconstitution, facilitating straightforward administration. FOCINVEZ is permitted for use amongst adults and children aged six months and above, and is given a distinct J-Code (J1434) for reimbursement purposes.

Which Companies Are Leading the Charge in Expanding theAntiemetics And Antinauseants Market Growth?

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

How is the Global Antiemetics And Antinauseants Market Segemented?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Which Geographics are Influencing the Growth of the Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Antiemetics And Antinauseants Market 2025, By The Business Research Company:

Metabolic Disorders Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Nootropics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nootropics-global-market-report

Dermatitis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: